HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption

• Main Authors: Eunice Akinyi Okumu (Author), Gail E. Henderson (Author), Carol Golin (Author), Kriste Kuczynski (Author), Nuchanart Q. Ormsby (Author), Holly L. Peay (Author)
• Format: Book
• Published: Elsevier, 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Early-phase HIV remission ("cure") trials aim to test interventions developed to eradicate HIV or to sustainably control HIV without antiretroviral treatment (ART). Many remission trials include analytic treatment interruption (ATI) to evaluate interventions, which increases the risk to pa...